Media
For media enquiries please contact:
media@evivebiotech.com
Latest Press Release
Evive Biotech Announces Recent Appointments: VP of Biometrics and VP of Clinical Operations
- 9 September 2021
Evive Biotech Announces IND Approval by the NMPA for a Phase II Clinical Study of F-652 in Patients with ACLF
- 8 September 2021
Evive Biotech Announces the Appointment of Dr. Lichuan Liu as Senior VP, Global Head of Clinical and Translational Science
- 2 September 2021
Evive Biotech Announces the Appointment of Dr. Weihai He as Senior VP, Global Head of Business Development
- 1 September 2021
Evive Biotech and Sino Biopharm Subsidiary Announce Strategic Collaboration to Commercialize F-627 in China
- 30 August 2021
Evive Biotech Announces the Appointment of Dr. Liping Sun as Senior VP, Global Head of R&D
- 8 July 2021
U.S. FDA Accepts Biologics License Application for Ryzneuta™
- 28 May 2021
Evive Biotech’s GMP Facility Receives Manufacture License of Pharmaceutical Products
- 7 April 2021
Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta™
- 31 March 2021
